EUVIMEDEUVIMED entdecken
Open Access

Ninjurin2 Promotes Pulmonary Endothelial Barrier Dysfunction Through VEGF / VEGFR2 Signaling Pathway

Huixin Peng, Yubing Yu, Liujinhong Han, Yuan He, Pengyun Wang, Jiahui Zhuo, Chengqi Xu, Huiying Liu iD

The FASEB Journal · 15.08.2026 · 40 (15)

DOI: 10.1096/fj.202600727r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 30.07.2026. Verfasst von Huixin Peng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities, First Affiliated Hospital of Shandong First Medical Universit…. Hauptthemen laut MEDLINE: Nerve Growth Factors, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor Receptor-2, Signal Transduction. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of Hubei Province, Beijing Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies have established an association between Ninjurin2 and diseases related to vascular endothelial dysfunction, such as ischemic stroke and coronary heart disease. Given that impaired pulmonary endothelial barrier function is a critical feature of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), we hypothesized that Ninjurin2 may also participate in the regulation of lung vascular permeability. Therefore, this study investigates the role of Ninjurin2 in regulating endothelial cell function and dysfunction, aiming to elucidate the underlying mechanisms in ALI and ARDS. This study utilized both animal models and in vitro experiments to investigate the role of Ninjurin2 in regulating endothelial cell function and dysfunction. Endothelial‐specific Ninjurin2 overexpressing ( NINJ2‐TG EC ) mice were generated and compared with control mice ( NINJ2 flox/flox ). To assess vascular permeability across various organs, we employed Evans Blue dye extravasation assays. At the cellular level, fluorescein isothiocyanate‐dextran (FITC‐dextran) flux assays were utilized to evaluate endothelial barrier integrity. Additionally, co‐immunoprecipitation (Co‐IP) and Western blotting were performed to investigate the interaction between Ninjurin2 and VEGFR2 and to analyze the activation of the VEGF/VEGFR2 signaling pathway. NINJ2‐TG EC mice developed severe lung injury with significantly increased vascular permeability in multiple organs. Overexpression of Ninjurin2 inhibited VE‐cadherin and ZO‐1 expression, leading to disruption of endothelial adherens and tight junctions and increased endothelial permeability in vivo and in vitro. Ninjurin2 bound directly to VEGFR2 and activated VEGFR2/AKT signaling and enhanced VEGF165‐induced barrier dysfunction. Pharmacological inhibition or genetic silencing of VEGFR2 reversed Ninjurin2‐mediated vascular leakage and pulmonary pathology. Furthermore, Ninjurin2 overexpression induced ROS accumulation, AKT/NF‐κB/ICAM‐1 activation, and monocyte‐endothelial adhesion. These data establish that Ninjurin2 compromises endothelial barrier integrity and promotes vascular inflammation through a VEGFR2‐dependent mechanism. Ninjurin2 exacerbates vascular endothelial hyperpermeability, particularly in the lungs, by interacting with VEGFR2 and activating the VEGF/VEGFR2 signaling pathway. The results suggest that Ninjurin2 could be a useful therapeutic target for ALI and ARDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nerve Growth FactorsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Signal TransductionCell Adhesion Molecules, NeuronalLungEndothelial CellsEndothelium, VascularAnimalsMiceAcute Lung InjuryMaleCapillary PermeabilityHumansMice, Inbred C57BL

Stichwörter der Autor:innen

ALIARDSNinjurin2VEGF/VEGFR2endothelial cell function and dysfunction

Substanzen

Nerve Growth FactorsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Cell Adhesion Molecules, NeuronalKdr protein, mousevascular endothelial growth factor A, mouseNinj1 protein, mouse

Autor:innen und Institutionen

  • Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities, First Affiliated Hospital of Shandong First Medical University/Shandong Province Qianfoshan Hospital, Shandong First Medical Univer…
  • Institute of Medical Genomics, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, NHC Key Laboratory of Biotechnology Drugs (Shandong Academy of Medical Sciences), First Affiliated Hospital of Shando…
  • College of Pulmonary and Critical Care Medicine, the 8th Medical Centre, Chinese PLA General Hospital, Beijing, P. R. China.
  • Department of Clinical Laboratory, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P. R. China.
  • Center for Human Genome Research, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.

ORCID-Profile: Huiying Liu

Förderung

  • the National Natural Science Foundation of China
  • National Natural Science Foundation of Hubei Province
  • Beijing Natural Science Foundation of China

Zitieren

APA

Peng, H., Yu, Y., Han, L., He, Y., Wang, P., Zhuo, J., Xu, C., & Liu, H. (2026). Ninjurin2 Promotes Pulmonary Endothelial Barrier Dysfunction Through VEGF / VEGFR2 Signaling Pathway. The FASEB Journal, 40(15). https://doi.org/10.1096/fj.202600727r

Vancouver

Peng H, Yu Y, Han L, He Y, Wang P, Zhuo J, et al. Ninjurin2 Promotes Pulmonary Endothelial Barrier Dysfunction Through VEGF / VEGFR2 Signaling Pathway. The FASEB Journal. 2026;40(15). doi:10.1096/fj.202600727r

BibTeX
@article{Peng2026,
  author = {Peng, Huixin and Yu, Yubing and Han, Liujinhong and He, Yuan and Wang, Pengyun and Zhuo, Jiahui and Xu, Chengqi and Liu, Huiying},
  title = {Ninjurin2 Promotes Pulmonary Endothelial Barrier Dysfunction Through VEGF / VEGFR2 Signaling Pathway},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {15},
  doi = {10.1096/fj.202600727r}
}
Kostenlos starten →